|
Volumn 6, Issue 17, 2008, Pages 3177-3185
|
Design and synthesis of bioactive 1,2-annulated adamantane derivatives
a a a b b c c |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIDES;
AMINES;
ARSENIC COMPOUNDS;
CHLORINE COMPOUNDS;
VIRUSES;
ADAMANTANE DERIVATIVES;
AMANTADINE;
INFLUENZA A VIRUS;
PYRROLIDINE;
RIBAVIRIN;
TRYPANOSOMA BRUCEI;
COMPLEXATION;
AMANTADINE;
ANTITRYPANOSOMAL AGENT;
ANTIVIRUS AGENT;
M2 PROTEIN, INFLUENZA A VIRUS;
MATRIX PROTEIN;
RIBAVIRIN;
RIMANTADINE;
AFRICAN TRYPANOSOMIASIS;
ANIMAL;
ARTICLE;
CHEMISTRY;
COMPARATIVE STUDY;
DRUG DESIGN;
DRUG EFFECT;
INFLUENZA VIRUS A H3N2;
METABOLISM;
ORTHOMYXOVIRUS INFECTION;
PATHOGENICITY;
SWINE;
SYNTHESIS;
TRYPANOSOMA BRUCEI;
AMANTADINE;
ANIMALS;
ANTIVIRAL AGENTS;
DRUG DESIGN;
INFLUENZA A VIRUS, H3N2 SUBTYPE;
ORTHOMYXOVIRIDAE INFECTIONS;
RIBAVIRIN;
RIMANTADINE;
SWINE;
TRYPANOCIDAL AGENTS;
TRYPANOSOMA BRUCEI BRUCEI;
TRYPANOSOMIASIS, AFRICAN;
VIRAL MATRIX PROTEINS;
INFLUENZA A VIRUS;
INFLUENZAVIRUS A;
TRYPANOSOMA;
TRYPANOSOMA BRUCEI;
|
EID: 49549099275
PISSN: 14770520
EISSN: None
Source Type: Journal
DOI: 10.1039/b804907f Document Type: Article |
Times cited : (38)
|
References (45)
|